The outlook is stable.
While the system has suffered “significant” operating losses in the past two years, such results are expected to improve, and the system enjoys strong integration and value-based care experience, the ratings agency said.
The rating does not include any reference to Risant Health, as that transaction is yet to be completed, but any Geisinger rating would not expect to be affected by such a transaction closing, S&P said.
Oakland, Calif.-based Kaiser Permanente agreed to acquire Geisinger on April 26 to help form Risant Health.
